David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
PUT
Devon Energy
DVN
$54B
| $63.9M | 0.06% |
1,709,700
+773,600
| +83% | +$27.5M |
|
377
Axsome Therapeutics
AXSM
$10.9B
| $63.9M | 0.06% |
547,665
+527,319
| +2,592% | +$60.1M |
|
378
First Citizens BancShares
FCNCA
$24.7B
| $63.7M | 0.06% |
34,347
-2,653
| -7% | -$5.4M |
|
379
Affirm
AFRM
$25.8B
| $63.6M | 0.06% |
1,408,058
-1,734,883
| -55% | -$103M |
|
380
CALL
Mercado Libre
MELI
$97.5B
| $63.6M | 0.06% |
32,600
-34,300
| -51% | -$68.1M |
|
381
Edwards Lifesciences
EW
$51.8B
| $63.4M | 0.06% |
874,406
-102,412
| -10% | -$7.33M |
|
382
Molina Healthcare
MOH
$10.5B
| $63M | 0.06% |
191,329
-27,550
| -13% | -$8.32M |
|
383
CALL
Royal Bank of Canada
RY
$285B
| $63M | 0.06% |
559,100
-215,000
| -28% | -$25.3M |
|
384
BlackBerry
BB
$4.71B
| $62.6M | 0.06% |
16,610,351
+10,657,317
| +179% | +$48.5M |
|
385
Applovin
APP
$102B
| $62.4M | 0.06% |
235,389
-1,205,728
| -84% | -$416M |
|
386
PTC
PTC
$16.8B
| $62.3M | 0.06% |
402,303
+83,255
| +26% | +$14.3M |
|
387
Life Time Group Holdings
LTH
$10.1B
| $62.1M | 0.06% |
2,056,864
+2,026,596
| +6,696% | +$59.5M |
|
388
PUT
Texas Instruments
TXN
$241B
| $61.3M | 0.05% |
341,000
-137,100
| -29% | -$25.7M |
|
389
Cboe Global Markets
CBOE
$31.4B
| $61.2M | 0.05% |
270,728
+139,932
| +107% | +$29M |
|
390
Globe Life
GL
$13.1B
| $61.1M | 0.05% |
464,104
-215,675
| -32% | -$26.4M |
|
391
Capital One
COF
$134B
| $61M | 0.05% |
340,409
+270,295
| +386% | +$51.1M |
|
392
Diageo
DEO
$52.6B
| $60.8M | 0.05% |
580,192
+560,262
| +2,811% | +$63.3M |
|
393
Trane Technologies
TT
$99.8B
| $60.5M | 0.05% |
179,529
+140,430
| +359% | +$50.7M |
|
394
CALL
Deere & Co
DE
$175B
| $60.4M | 0.05% |
128,600
+60,000
| +87% | +$28.1M |
|
|
B
395
PUT
Barrick Mining
B
$78.3B
| $60.1M | 0.05% |
3,092,300
+315,800
| +11% | +$5.53M |
|
396
Kinder Morgan
KMI
$69B
| $60.1M | 0.05% |
2,105,938
+1,694,781
| +412% | +$46.9M |
|
397
Vistra
VST
$45.7B
| $59.6M | 0.05% |
507,097
+501,397
| +8,796% | +$74.9M |
|
398
PUT
Albemarle
ALB
$16.9B
| $59.1M | 0.05% |
820,700
-110,800
| -12% | -$9.02M |
|
399
CALL
Procter & Gamble
PG
$336B
| $58.8M | 0.05% |
344,800
-140,300
| -29% | -$23.5M |
|
400
W.W. Grainger
GWW
$61.8B
| $58.4M | 0.05% |
59,134
+17,620
| +42% | +$18.2M |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.